FOUNTAIN VALLEY, CA & VANCOUVER, British Columbia – (COMMERCIAL THREAD) – Lab Genomics, a personalized medicine company providing cutting-edge molecular genetic testing in Southern California and other parts of the United States, today, in partnership with Canexia Health, announced that MolDX has finalized the coverage determination under the ‘Plasma-Based Genomic Profiling in Solid Tumors’ policy for Follow It, a circulating tumor DNA (ctDNA) assay. The coverage decision provides for Medicare reimbursement of Follow It for use in breast, lung and colorectal cancers.
Follow It, which requires only a simple blood sample from patients, analyzes cDNA in plasma to assess somatic mutations in 337 hotspots and 26 exons in 38 cancer-associated genes. This information can be used to guide the selection of a targeted therapy, which has been shown to improve patient outcomes up to three times.
âMedicare coverage for liquid biopsy is an essential step in helping cancer patients access targeted therapies,â said Leena Dalal, founder of Lab Genomics. âWe congratulate MolDX on this decision which supports our focus on providing individualized medical care. ”
âThe Follow It reimbursement significantly expands access to a minimally invasive screening test for cancer treatment for some of the most common forms of solid tumor cancer,â said Michael Ball, CEO of Canexia Health. âThis MolDX decision marks an important step in our mission to transform cancer care. ”
About Canexia Health
Canexie Health makes high-quality cancer genomic information accessible and affordable with our clinically validated tests, informatics and support. Our clinically actionable and cost-effective suite of cancer-based tests designed to improve cancer treatment and surveillance. With our extensive scientific experience, our specialized genomics-based testing and the support of pharmaceutical and diagnostic partners, we are leading the transition to precision oncology.
About genomics in the laboratory
Lab Genomics, LLC was cultivated with the ideal in mind of providing cutting-edge molecular genetic testing with the end goal of the best possible quality of life for the patient. Lab Genomics is focused on providing individualized medical care through its robust molecular and genetic diagnostics. The Lab Genomics team is made up of highly qualified experts in the medical and genetic fields.